a month ago
JAZZ
AnalystsJoel BeattyJoel Beatty's Stock Forecasts
AnalystsJoel Beatty
Analyst Ranking
Top 8%
#386 out of 5150 analysts
Average Return
+13.6%
Win Rate
49%79 out of 162
Risk vs Reward
Poor
Good
Joel Beatty's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Praxis Precision Medicines IncPRAX | +701.19% | $33.55 | $268.80 | 2025-03-03 - 2025-12-12 | Buy |
Cymabay Therapeutics IncCBAY | +258.57% | $1.40 | $5.02 | 2020-03-20 - 2021-03-19 | Strong Buy |
Ambrx Biopharma IncAMAM | +252.16% | $7.86 | $27.68 | 2023-04-05 - 2024-01-16 | Buy |
Novavax IncNVAX | +203.39% | $88.60 | $268.80 | 2014-08-13 - 2015-08-13 | Strong Buy |
Esperion Therapeutics IncESPR | +197.78% | $26.17 | $77.93 | 2017-02-28 - 2018-01-22 | Strong Buy |
Joel Beatty Analyst Color
Get additional color on Joel Beatty's coverage of popular stocks
10 months ago
CPRX
a year ago
ELF
a year ago
ELF
2 years ago
AMLX
Joel Beatty's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Contineum Therapeutics IncCTNM | 3 | Buy | $14.00 | +20.38% | Maintains | 21 days ago |
Jazz Pharmaceuticals PLCJAZZ | 5 | Buy | $209.00 | +24.78% | Maintains | a month ago |
Elf Beauty IncELF | 9 | Buy | $125.00 | +63.70% | Maintains | a month ago |
Amylyx Pharmaceuticals IncAMLX | 5 | Buy | $19.00 | +45.04% | Maintains | 2 months ago |
Larimar Therapeutics IncLRMR | 3 | Buy | $7.00 | +72.84% | Maintains | 3 months ago |
Dianthus Therapeutics IncDNTH | 3 | Buy | $67.00 | +59.03% | Maintains | 3 months ago |
Editas Medicine IncEDIT | 5 | Buy | $6.00 | +137.15% | Maintains | 4 months ago |
Cogent Biosciences IncCOGT | 6 | Hold | $9.00 | -78.63% | Maintains | 5 months ago |
Sage Therapeutics IncSAGE | 5 | Hold | $9.00 | +3.69% | Maintains | 6 months ago |
Acadia Pharmaceuticals IncACAD | 4 | Buy | $31.00 | +14.18% | Maintains | 7 months ago |
Neurogene IncNGNE | 5 | Hold | $24.00 | +14.72% | Downgrades | 7 months ago |
Argenx SeARGX | 7 | Buy | $680.00 | -22.55% | Upgrades | 7 months ago |
Denali Therapeutics IncDNLI | 2 | Buy | $29.00 | +61.29% | Maintains | 7 months ago |
Ptc Therapeutics IncPTCT | 11 | Buy | $66.00 | -12.74% | Maintains | 7 months ago |
Axsome Therapeutics IncAXSM | 5 | Buy | $162.00 | +9.33% | Maintains | 7 months ago |
Alkermes PLCALKS | 3 | Buy | $41.00 | +43.86% | Maintains | 7 months ago |
Mind Medicine IncMNMD | 2 | Buy | $16.00 | +27.49% | Maintains | 9 months ago |
Praxis Precision Medicines IncPRAX | 2 | Buy | $73.00 | -72.84% | Maintains | 9 months ago |
Catalyst Pharmaceuticals IncCPRX | 2 | Buy | $32.00 | +35.48% | Maintains | 9 months ago |
Blueprint Medicines CorpBPMC | 3 | Buy | $135.00 | +4.28% | Maintains | 10 months ago |
Bright Minds Biosciences IncDRUG | 1 | Buy | $75.00 | N/A | Initiates Coverage On | a year ago |
Immutep LtdIMMP | 5 | Buy | $7.00 | N/A | Maintains | a year ago |
Biomarin Pharmaceutical IncBMRN | 5 | Hold | $65.00 | N/A | Maintains | a year ago |
Longboard Pharmaceuticals IncLBPH | 2 | Buy | $60.00 | N/A | Maintains | a year ago |
Ultragenyx Pharmaceutical IncRARE | 4 | Buy | $72.00 | N/A | Maintains | 2 years ago |
Calidi Biotherapeutics IncCLDI | 3 | Buy | $240.00 | N/A | Maintains | 2 years ago |
Geron CorpGERN | 2 | Hold | $4.50 | N/A | Downgrades | 2 years ago |
Intra Cellular Therapies IncITCI | 2 | Buy | $103.00 | N/A | Maintains | 2 years ago |
Nurix Therapeutics IncNRIX | 2 | Buy | $25.00 | N/A | Maintains | 2 years ago |
Cypherpunk Technologies IncCYPH | 2 | Buy | $9.00 | N/A | Maintains | 2 years ago |
Ambrx Biopharma IncAMAM | 3 | Hold | $28.00 | N/A | Downgrades | 2 years ago |
Syndax Pharmaceuticals IncSNDX | 2 | Buy | $28.00 | N/A | Maintains | 2 years ago |
Vaxxinity IncVAXX | 1 | Buy | $7.00 | N/A | Initiates Coverage On | 2 years ago |
Tracon Pharmaceuticals IncTCON | 3 | Buy | $60.00 | N/A | Maintains | 2 years ago |
Inmune Bio IncINMB | 1 | Buy | $16.00 | N/A | Initiates Coverage On | 3 years ago |
Chimerix IncCMRX | 1 | Buy | $7.00 | N/A | Initiates Coverage On | 3 years ago |
Beyondspring IncBYSI | 2 | Buy | $1.25 | N/A | Maintains | 3 years ago |
Pliant Therapeutics IncPLRX | 3 | Buy | $44.00 | N/A | Initiates Coverage On | 3 years ago |
Arrowhead Pharmaceuticals IncARWR | 2 | Buy | $58.00 | N/A | Maintains | 3 years ago |
Ideaya Biosciences IncIDYA | 2 | Buy | $24.00 | N/A | Maintains | 3 years ago |
Arcturus Therapeutics Holdings IncARCT | 2 | Sell | $18.00 | N/A | Downgrades | 3 years ago |
Cardiff Oncology IncCRDF | 2 | Buy | $6.00 | N/A | Maintains | 3 years ago |
Igm Biosciences IncIGMS | 2 | Buy | $31.00 | N/A | Maintains | 4 years ago |
Vir Biotechnology IncVIR | 2 | Hold | $28.00 | N/A | Upgrades | 4 years ago |
Alnylam Pharmaceuticals IncALNY | 2 | Hold | $175.00 | N/A | Downgrades | 5 years ago |
Vanda Pharmaceuticals IncVNDA | 4 | Hold | $14.00 | N/A | Downgrades | 5 years ago |
Sarepta Therapeutics IncSRPT | 2 | Hold | $108.00 | N/A | Downgrades | 5 years ago |
Eidos Therapeutics IncEIDX | 2 | Hold | $73.26 | N/A | Downgrades | 5 years ago |
Eloxx Pharmaceuticals IncELOX | 1 | Hold | $160.00 | N/A | Downgrades | 6 years ago |
Ayala Pharmaceuticals IncAYLA | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 6 years ago |
Tempest Therapeutics IncTPST | 2 | Strong Buy | $6.00 | N/A | Reinstates | 6 years ago |
Ionis Pharmaceuticals IncIONS | 2 | Strong Buy | $71.00 | N/A | Maintains | 6 years ago |
Phasebio Pharmaceuticals IncPHASQ | 1 | Strong Buy | $11.00 | N/A | Maintains | 6 years ago |
Dbv Technologies SaDBVT | 2 | Strong Buy | $100.00 | N/A | Maintains | 6 years ago |
Amarin Corp PLCAMRN | 12 | Strong Buy | $120.00 | N/A | Maintains | 6 years ago |
Ngm Biopharmaceuticals IncNGM | 1 | Strong Buy | $28.00 | N/A | Maintains | 6 years ago |
X4 Pharmaceuticals IncXFOR | 1 | Strong Buy | $450.00 | N/A | Maintains | 6 years ago |
Cymabay Therapeutics IncCBAY | 1 | Strong Buy | $1.60 | N/A | Maintains | 6 years ago |
Esperion Therapeutics IncESPR | 5 | Strong Buy | N/A | N/A | Upgrades | 6 years ago |
Intercept Pharmaceuticals IncICPT | 5 | Strong Buy | N/A | N/A | Upgrades | 6 years ago |
Medicines CoMDCO | 3 | Strong Buy | $50.00 | N/A | Maintains | 7 years ago |
Atyr Pharma IncATYR | 4 | Hold | $10.50 | N/A | Upgrades | 7 years ago |
Astria Therapeutics IncATXS | 3 | Strong Buy | $1.50 | N/A | Maintains | 7 years ago |
Arena Pharmaceuticals IncARNA | 3 | Strong Buy | $55.00 | N/A | Maintains | 8 years ago |
Novavax IncNVAX | 7 | Hold | $55.00 | N/A | Maintains | 8 years ago |
Kura Oncology IncKURA | 1 | Strong Buy | $19.00 | N/A | Maintains | 8 years ago |
Dimension Therapeutics IncDMTX | 3 | Hold | N/A | N/A | Upgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.